Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:HTGMNASDAQ:HTGMQNASDAQ:OMICNASDAQ:TLIS On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeHTGMHTG Molecular Diagnostics$6.00$3.50▼$7.95N/A0.99294,806 shs773,040 shsHTGMQHTG Molecular Diagnostics$0.00$0.00▼$0.02N/A2.722,292 shsN/AOMICSingular Genomics Systems$20.01$20.01$5.34▼$23.41$50.83M1.8349,533 shsN/ATLISTalis Biomedical$1.43$1.51$1.04▼$9.35$2.61M1.32,744 shs15 shsThe 10 Best AI Stocks to Own in 2025Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceHTGMHTG Molecular Diagnostics0.00%0.00%0.00%0.00%0.00%HTGMQHTG Molecular Diagnostics0.00%0.00%0.00%0.00%-93.33%OMICSingular Genomics Systems0.00%0.00%0.00%0.00%+80.27%TLISTalis Biomedical0.00%-18.29%-4.67%-17.82%-83.18%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationHTGMHTG Molecular DiagnosticsN/AN/AN/AN/AN/AN/AN/AN/AHTGMQHTG Molecular DiagnosticsN/AN/AN/AN/AN/AN/AN/AN/AOMICSingular Genomics SystemsN/AN/AN/AN/AN/AN/AN/AN/ATLISTalis Biomedical0.1846 of 5 stars0.01.00.00.00.02.50.6Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceHTGMHTG Molecular Diagnostics 0.00N/AN/AN/AHTGMQHTG Molecular Diagnostics 0.00N/AN/AN/AOMICSingular Genomics Systems 2.00Hold$6.50-67.52% DownsideTLISTalis Biomedical 0.00N/AN/AN/ACurrent Analyst Ratings BreakdownCompare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookHTGMHTG Molecular Diagnostics$6.37M0.00N/AN/A$2.44 per share0.00HTGMQHTG Molecular Diagnostics$6.37M0.00N/AN/AN/ANaNOMICSingular Genomics Systems$2.91M17.47N/AN/A$73.25 per share0.27TLISTalis Biomedical$300K8.69N/AN/A$37.95 per share0.04Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateHTGMHTG Molecular Diagnostics-$21.59MN/A0.00N/AN/A-324.25%45.52%8.93%N/AHTGMQHTG Molecular Diagnostics-$21.59MN/A0.00N/AN/AN/AN/AN/AN/AOMICSingular Genomics Systems-$94.82M-$35.11N/A∞N/A-3,237.89%-57.87%-37.90%8/12/2025 (Estimated)TLISTalis Biomedical-$62.01M-$28.02N/A∞N/AN/A-79.74%-57.16%8/18/2025 (Estimated)Compare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthHTGMHTG Molecular DiagnosticsN/AN/AN/AN/AN/AHTGMQHTG Molecular DiagnosticsN/AN/AN/AN/AN/AOMICSingular Genomics SystemsN/AN/AN/AN/AN/ATLISTalis BiomedicalN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioHTGMHTG Molecular DiagnosticsN/A1.401.30HTGMQHTG Molecular DiagnosticsN/AN/AN/AOMICSingular Genomics Systems0.047.376.67TLISTalis BiomedicalN/A7.767.76Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipHTGMHTG Molecular Diagnostics19.27%HTGMQHTG Molecular DiagnosticsN/AOMICSingular Genomics Systems65.80%TLISTalis Biomedical43.77%Insider OwnershipCompanyInsider OwnershipHTGMHTG Molecular Diagnostics2.60%HTGMQHTG Molecular Diagnostics2.60%OMICSingular Genomics Systems22.20%TLISTalis Biomedical46.00%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableHTGMHTG Molecular Diagnostics842.21 million2.16 millionOptionableHTGMQHTG Molecular Diagnostics902.21 million2.16 millionNot OptionableOMICSingular Genomics Systems2202.54 million1.97 millionNo DataTLISTalis Biomedical2601.82 million984,000No DataHTGM, HTGMQ, OMIC, and TLIS HeadlinesRecent News About These CompaniesTalis Biomedical (NASDAQ:TLIS) Stock Price Down 18.3% - Here's What HappenedJune 26 at 2:59 AM | americanbankingnews.comBaker Bros. Advisors LP's Strategic Acquisition in Talis Biomedical CorpOctober 10, 2024 | finance.yahoo.comTalis Biomedical Agrees to Settle Investor Suit for $33 MillionOctober 3, 2024 | news.bloomberglaw.comNTalis Biomedical Corp Ordinary SharesSeptember 17, 2024 | morningstar.comMInsider Buying: Talis Biomedical Co. (NASDAQ:TLIS) Major Shareholder Buys 13,167 Shares of StockAugust 29, 2024 | insidertrades.comTalis Biomedical Shares Fall on Bankruptcy Filing, Delisting NoticeAugust 24, 2024 | marketwatch.comTLIS Stock Earnings: Talis Biomedical Reported Results for Q2 2024August 19, 2024 | investorplace.comTalis Biomedical Shares Tumble Premarket as Company Mulls BankruptcyAugust 7, 2024 | marketwatch.comWhy Talis Biomedical (TLIS) Stock Is Getting Obliterated TodayAugust 7, 2024 | benzinga.comWhy Is Talis Biomedical (TLIS) Stock Down 52% Today?August 7, 2024 | investorplace.com(TLIS) Trading ReportJuly 25, 2024 | news.stocktradersdaily.comNTalis Biomedical Corp (TLIS)May 10, 2024 | investing.comTLIS Stock Earnings: Talis Biomedical Reported Results for Q1 2024May 8, 2024 | investorplace.comBragar Eagel & Squire is Investigating Certain Officers and Directors of Talis, TaskUs, and ...April 27, 2024 | eagletribune.comETalis Biomedical Corporation (TLIS)March 31, 2024 | finance.yahoo.comGrabar Law Office Investigates Claims on Behalf of Shareholders of Talis Biomedical CorporationFebruary 16, 2024 | markets.businessinsider.comTLIS Feb 2024 2.500 putFebruary 15, 2024 | finance.yahoo.comPeninsula diagnostics company to close Redwood City labs and offices, pursue 'strategic alternatives'November 14, 2023 | bizjournals.comTalis Biomedical Corporation: Talis Biomedical Announces Exploration of Strategic Alternatives and Cost Reduction Plan to Preserve CashNovember 14, 2023 | finanznachrichten.deLICY, BTAI and HROW among mid-day moversNovember 14, 2023 | msn.comNew MarketBeat Followers Over TimeTop HeadlinesView All HeadlinesMore Than a Monetary Metal: Silver's Case for OutperformanceBy Jeffrey Neal Johnson | June 22, 2025View More Than a Monetary Metal: Silver's Case for OutperformanceHigher Gulf Oil Output Puts These Energy Names in PlayBy Gabriel Osorio-Mazilli | June 13, 2025View Higher Gulf Oil Output Puts These Energy Names in Play3 Hot Trades for Insiders, But Are They Good Buys for Investors?By Thomas Hughes | June 24, 2025View 3 Hot Trades for Insiders, But Are They Good Buys for Investors?JPMorgan Chase: The Financial Fortress Built for Today's InvestorBy Jeffrey Neal Johnson | June 23, 2025View JPMorgan Chase: The Financial Fortress Built for Today's InvestorWhich U.S. Towns See Economic Change First? [2025 Survey]By MarketBeat Staff | June 9, 2025View Which U.S. Towns See Economic Change First? [2025 Survey]HTGM, HTGMQ, OMIC, and TLIS Company DescriptionsHTG Molecular Diagnostics NASDAQ:HTGMHTG Molecular Diagnostics, Inc. engages in the provision of molecular technology solutions that facilitates molecular profiling. It serves the biopharmaceutical companies, academic research centres, and molecular testing laboratories. Its proprietary HTG EdgeSeq technology automates complex, highly multiplexed molecular profiling from solid and liquid samples, even when limited in amount. The company was founded by Bruce E. Seligmann in October 1997 and is headquartered in Tucson, AZ.HTG Molecular Diagnostics NASDAQ:HTGMQHTG Molecular Diagnostics, Inc. a life sciences company, focuses on the precision medicine. The company offers instruments; consumables; and software that automate sample processing and profiles various molecular targets. Its marketed molecular profiling panels include HTG Transcriptome Panel; HTG EdgeSeq precision immuno-oncology panel; HTG EdgeSeq miRNA whole-transcriptome assay; HTG EdgeSeq DLBCL cell of origin assay EU; HTG EdgeSeq Oncology Biomarker Panel; HTG immune response panel; and HTG mouse mRNA tumor response panel. The company distributes its instruments and consumables directly in the United States and Europe; and through distributors in parts of Europe and internationally. It serves biopharmaceutical companies, academic research centers, and molecular testing laboratories. The company was formerly known as HTG, Inc. and changed its name to HTG Molecular Diagnostics, Inc. in March 2011. HTG Molecular Diagnostics, Inc. was incorporated in 1997 and is based in Tucson, Arizona. On June 5, 2023, HTG Molecular Diagnostics, Inc. filed a voluntary petition for reorganization under Chapter 11 in the U.S. Bankruptcy Court for the District of Delaware.Singular Genomics Systems NASDAQ:OMIC$20.01 0.00 (0.00%) As of 02/21/2025Singular Genomics Systems, Inc., a life science technology company, develops next generation sequencing and multiomics technology for researchers and clinicians to advance science and medicine. The company is involved in the developing of G4, consisting of G4 instrument and associated consumables for various applications, such as max read kits for single cell sequencing, rare variant detection with high-definition sequencing, gene fusion detection with ring-seq, and extended range sequencing; and PX instrument and associated consumables for applications comprising single cell gene expression and proteomics, in situ RNA sequencing, and spatial RNA and proteomics applications for tissue. Singular Genomics Systems, Inc. was incorporated in 2016 and is based in San Diego, California.Talis Biomedical NASDAQ:TLIS$1.43 0.00 (0.00%) As of 06/25/2025Talis Biomedical Corporation operates as a molecular diagnostic company, focusing on developing medical devices for infectious diseases and other conditions at the point of care in the United States. Talis Biomedical Corporation was incorporated in 2013 and is headquartered in Chicago, Illinois. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas NVIDIA’s Stock Price Hits New Highs: This Is What’s Next Micron: A Hot Buy Heats Up, Fresh All-Time Highs Are Coming Super Micro’s Bold $2B Bond Plan Signals 35% Premium Upside Is IBM’s AI Transformation Powering a Sustained Rally? Analysts Supercharge AMD Stock Ahead of Q2 AI Catalyst Amazon: Why Some Are Growing Bearish, and Why They’re Wrong ASML Keeps Buying Back Its Own Stock—Chasing Discount and Upside Astera Labs: AI Infrastructure Play With Significant Growth Ahead Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
